SEARCH

SEARCH BY CITATION

References

  • Agarwal A., Nandipati KC, Sharma RK, Zippe CD, Raina R.. Role of oxidative stress in the pathophysiological mechanism of erectile dysfunction. J Androl. 2006;27(3): 335347.
  • Ali ST, Shaikh RN, Siddiqi NA, Siddiqi PQ. Semen analysis in insulin-dependent/non-insulin-dependent diabetic men with/without neuropathy. Arch Androl. 1993;30(1): 4754.
  • Amatruda JM, Harman SM, Pourmotabbed G., Lockwood DH. Depressed plasma testosterone and fractional binding of testosterone in obese males. J Clin Endocrinol Metab. 1978;47(2): 268271.
  • Andersen P., Seljeflot I., Herzog A., Arnesen H., Hjermann I., Holme I.. Effects of doxazosin and atenolol on atherothrombogenic risk profile in hypertensive middle-aged men. J Cardiovasc Pharmacol. 1998;31(5): 677683.
  • Andersson B., Mårin P., Lissner L., Vermeulen A., Björntorp P.. Testosterone concentrations in women and men with NIDDM. Diabetes Care. 1994;5(17): 405411.
  • Barqawi A., Caruso A., Meacham RB. Experimental varicocele induces testicular germ cell apoptosis in the rat. J Urol. 2004;171(1): 501503.
  • Barrett-Connor E., Khaw KT, Yen SS. Endogenous sex hormone levels in older adult men with diabetes mellitus. Am J Epidemiol. 1990;132(5): 895901.
  • Boyanov MA, Boneva Z., Christov VG. Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency. Aging Male. 2003;6(1): 17.
  • Braun M., Wassmer G., Klotz T., Reifenrath B., Mathers M., Engelmann U.. Epidemiology of erectile dysfunction: results of the ‘Cologne Male Survey.’ Int J Impot Res. 2000;12(6): 305311.
  • Chang TC, Tung CC, Hsiao YL. Hormonal changes in elderly men with non-insulin-dependent diabetes mellitus and the hormonal relationships to abdominal adiposity. Gerontology. 1994;40(5): 260267.
  • Corona G., Mannucci E., Schulman C., Petrone L., Mansani R., Cilotti A., Balercia G., Chiarini V., Forti G., Maggi M.. Psychobiologic correlates of the metabolic syndrome and associated sexual dysfunction. Eur Urol. 2006;50(3): 595604; discussion 604.
  • Dandona P., Aljada A., Chaudhuri A., Mohanty P., Garg R.. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation. 2005;111(11): 14481454.
  • Davi G., Falco A.. Oxidant stress, inflammation and atherogenesis. Lupus. 2005;14(9): 760764.
  • de Berardis G., Pellegrini F., Franciosi M., Belfiglio M., Di Nardo B., Greenfield S., Kaplan SH, Rossi MC, Sacco M., Tognoni G., Valentini M., Nicolucci A.. Identifying patients with type 2 diabetes with a higher likelihood of erectile dysfunction: the role of the interaction between clinical and psychological factors. J Urol. 2003;169(4): 14221428.
  • Demir T.. Prevalence of erectile dysfunction in patients with metabolic syndrome. Int J Urol. 2006;13(4): 385388.
  • Dhindsa S., Prabhakar S., Sethi M., Bandyopadhyay A., Chaudhuri A., Dadonda P.. Frequent occurrence of hypogonadotropic hypogonadism in type 2diabetes. J Clin Endocrinol Metab. 2004;89(11): 54625468.
  • Dockery F., Bulpitt CJ, Agarwal S., Rajkumar C.. Testosterone suppression in men with prostate cancer is associated with increased arterial stiffness. Aging Male. 2002;5(4): 216222.
  • Dockery F., Bulpitt CJ, Donaldson M., Fernandez S., Rajkumar C.. The relationship between androgens and arterial stiffness in older men. J Am Geriatr Soc. 2003;51(11): 16271632.
  • Dockery F., Rajkumar C., Agarwal S., Waxman J., Bulpitt CJ. Androgen deprivation in males is associated with decreased central arterial compliance and reduced central systolic blood pressure. J Hum Hypertens. 2000;14(6): 395397.
  • Esposito K., Giugliano F., Martedi E., Feola G., Marfella R., D'Armiento M., Giugliano D.. High proportions of erectile dysfunction in men with the metabolic syndrome. Diabetes Care. 2005;28(5): 12011203.
  • Fejes I., Koloszar S., Szollosi J., Zavaczki Z., Pal A.. Is semen quality affected by male body fat distribution? Andrologia. 2005;37(5): 155159.
  • Fogari R., Preti P., Derosa G., Marasi G., Zoppi A., Rinaldi A., Mugellini A.. Effect of antihypertensive treatment with valsartan or atenolol on sexual activity and plasma testosterone in hypertensive men. Eur J Clin Pharmacol. 2002;58(3): 177180.
  • Fogari R., Zoppi A., Preti P., Rinaldi A., Marasi G., Vanasia A., Mugellini A.. Sexual activity and plasma testosterone levels in hypertensive males. Am J Hypertens. 2002;15(3): 217221.
  • Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002;287(3): 356359.
  • Glass AR, Swerdloff RS, Bray GA, Dahms WT, Atkinson RL. Low serum testosterone and sex-hormone-binding-globulin in massively obese men. J Clin Endocrinol Metab. 1977;45(6): 12111219.
  • Haffner SM. The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease. Am J Cardiol. 2006;97(2A): 3A11A.
  • Haffner SM, Shaten J., Stern MP, Smith GD, Kuller L.. Low levels of sex hormone-binding globulin and testosterone predict the development of non-insulin-dependent diabetes mellitus in men. MRFIT Research Group. Multiple Risk Factor Intervention Trial. Am J Epidemiol. 1996;143(9): 889897.
  • Handel LN, Shetty R., Sigman M.. The relationship between varicoceles and obesity. J Urol. 2006;176(5): 21382140; discussion 2140.
  • Hughes GS, Mathur RS, Margolius HS. Sex steroid hormones are altered in essential hypertension. J Hypertens. 1989;7(3): 181187.
  • Jarow JP, Kirkland J., Koritnik DR, Cefalu WT. Effect of obesity and fertility status on sex steroid levels in men. Urology. 1993;42(2): 171174.
  • Johannes CB, Araujo AB, Feldman HA, Derby CA, Kleinman KP, McKinlay JB. Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts male aging study. J Urol. 2000;163(2): 460463.
  • Kaplan SA, Meehan AG, Shah A.. The age related decrease in testosterone is significantly exacerbated in obese men with the metabolic syndrome. What are the implications for the relatively high incidence of erectile dysfunction observed in these men? J Urol. 2006;176(4 Pt 1): 15241527; discussion 1527–1528.
  • Khaw KT, Barrett-Connor E.. Blood pressure and endogenous testosterone in men: an inverse relationship. J Hypertens. 1988;6(4): 329332.
  • Kley HK, Deselaers T., Peerenboom H., Kruskemper HL. Enhanced conversion of androstenedione to estrogens in obese males. J Clin Endocrinol Metab. 1980;51(5): 11281132.
  • Kodama H., Yamaguchi R., Fukuda J., Kasai H., Tanaka T.. Increased oxidative deoxyribonucleic acid damage in the spermatozoa of infertile male patients. Fertil Steril. 1997;68(3): 519524.
  • Kort HI, Massey JB, Elsner CW, Mitchell-Leef D., Shapiro DB, Witt MA, Roudebush WE. Impact of body mass index on sperm quantity and quality. J Androl. 2006;27(3): 450452.
  • Koshida H., Takeda R., Miyamori I.. Lisinopril decreases plasma free testosterone in male hypertensive patients and increases sex hormone binding globulin in female hypertensive patients. Hypertens Res. 1998;21(4): 279282.
  • Kupelian V., Shabsigh R., Araujo AB, O'Donnell AB, McKinlay JB. Erectile dysfunction as a predictor of the metabolic syndrome in aging men: results from the Massachusetts Male Aging Study. J Urol. 2006;176(1): 222226.
  • Laaksonen DE, Niskanen L., Punnonen K., Nyyssonen K., Tuomainen TP, Salonen R., Rauramaa R., Salonen JT. Sex hormones, inflammation and the metabolic syndrome: a population-based study. Eur J Endocrinol. 2003;149(6): 601608.
  • Magnusdottir EV, Thorsteinsson T., Thorsteinsdottir S., Heimisdottir M., Olafsdottir K.. Persistent organochlorines, sedentary occupation, obesity and human male subfertility. Hum Reprod. 2005;20(1): 208215.
  • Makhside N.. Hypogonadism and metabolic syndrome: implications for testosterone therapy. J Urol. 2005;3(174): 827834.
  • Malik S., Wong ND, Franklin S., Pio J., Fairchild C., Chen R.. Cardiovascular disease in U.S. patients with metabolic syndrome, diabetes, and elevated C-reactive protein. Diabetes Care. 2005;28(3): 690693.
  • Muller M., Grobbee DE, den Tonkelaar I., Lamberts SW, van Der Schouw YT. Endogenous sex hormones and metabolic syndrome in aging men. J Clin Endocrinol Metab. 2005;90(5): 26182623.
  • Nicolosi A., Moreira ED Jr, Shirai M., Bin MI, Glasser DB. Epidemiology of erectile dysfunction in four countries: cross-national study of the prevalence and correlates of erectile dysfunction. Urology. 2003;61(1): 201206.
  • Nielsen ME, Zderic S., Freedland SJ, Jarow JP. Insight on pathogenesis of varicoceles: relationship of varicocele and body mass index. Urology. 2006;68(2): 392396.
  • Oh JY, Barrett-Connor E., Wedick NM, Wingard DL. Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study. Diabetes Care. 2002;25(1): 5560.
  • Osuna JA, Gomez-Perez R., Arata-Bellabarba G., Villaroel V.. Relationship between BMI, total testosterone, sex hormone-binding-globulin, leptin, insulin and insulin resistance in obese men. Arch Androl. 2006;52(5): 355361.
  • Pasquali R., Casimirri F., de Iasio R., Mesini P., Boschi S., Chierici R., Flamia R., Biscotti M., Vicennati V.. Insulin regulates testosterone and sex hormone-binding globulin concentrations in adult normal weight and obese men. J Clin Endocrinol Metab. 1995;80(2): 654658.
  • Phillips GB. Relationship between serum sex hormones and the glucose-insulin-lipid defect in men with obesity. Metabolism. 1993;42(1): 116120.
  • Phillips GB, Jing TY, Resnick LM, Barbagallo M., Laragh JH, Sealey JE. Sex hormones and hemostatic risk factors for coronary heart disease in men with hypertension. J Hypertens. 1993;11(7): 699702.
  • Pitteloud N., Hardin M., Dwyer AA, Valassi E., Yialamas M., Elahi D., Hayes FJ. Increasing insulin resistance is associated with a decrease in Leydig cell testosterone secretion in men. J Clin Endocrinol Metab. 2005;90(5): 26362641.
  • Plymate SR, Matej LA, Jones RE, Friedl KE. Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin. J Clin Endocrinol Metab. 1988;67(3): 460464.
  • Prabakaran S., Kumanov P., Tomova A., Hubaveshki S., Agarwal A.. Adolescent varicocele: association with somatometric parameters. Urol Int. 2006;77(2): 114117.
  • Ramirez-Torres MA, Carrera A., Zambrana M.. [High incidence of hyperestrogenemia and dyslipidemia in a group of infertile men]. Ginecol Obstet Mex. 2000;68(1): 224229.
  • Robeva R., Kirilov G., Tomova A., Kumanov P.. Low testosterone levels and unimpaired melatonin secretion in young males with metabolic syndrome. Andrologia. 2006;38(6): 216220.
  • Schlesinger MH, Wilets IF, Nagler HM. Treatment outcome after varicocelectomy. A critical analysis. Urol Clin North Am. 1994;21(3): 517529.
  • Schneider G., Kirschner MA, Berkowitz R., Ertel NH. Increased estrogen production in obese men. J Clin Endocrinol Metab. 1979;48(4): 633638.
  • Seidell JC, Bjorntorp P., Sjostrom L., Kvist H., Sannerstedt R.. Visceral fat accumulation in men is positively associated with insulin, glucose, and C-peptide levels, but negatively with testosterone levels. Metabolism. 1990;39(9): 897901.
  • Sexton WJ, Jarow JP. Effect of diabetes mellitus upon male reproductive function. Urology. 1997;49(4): 508513.
  • Shaban S., Seaman E., Lipschultz LI. Treatment of abnormalities of ejaculation. In: Lipschultz LI, Howards SS eds. Infertility in the Male. 3rd ed. St. Louis: Mosby Year Book, 1991: 423438.
  • Shafik A., Olfat S.. Lipectomy in the treatment of scrotal lipomatosis. Br J Urol. 1981a;53(1): 5561.
  • Shafik A., Olfat S.. Scrotal lipomatosis. Br J Urol. 1981b;53(1): 5054.
  • Shalaby MA, El-Zorba HY, Kamel GM. Effect of alpha-tocopherol and simvastatin on male fertility in hypercholesterolemic rats. Pharmacol Res. 2004;50(2): 137142.
  • Sigman M., Jarow J.. Male infertility. In: Walsh, ed. Campbell's Urology. 8th ed. Philadelphia: Saunders; 2002; 14751531.
  • Stellato RK, Feldman HA, Hamdy O., Horton ES, McKinlay JB. Testosterone, sex hormone-binding globulin, and the development of type 2diabetes in middle-aged men: prospective results from the Massachusetts male aging study. Diabetes Care. 2000;23(4): 490494.
  • Strain GW, Zumoff B., Kream J., Strain JJ, Deucher R., Rosenfeld RS, Levin J., Fukushima DK. Mild hypogonadotropic hypogonadism in obese men. Metabolism. 1982;31(9): 871875.
  • Suzuki H., Tominaga T., Kumagai H., Saruta T.. Effects of first-line antihypertensive agents on sexual function and sex hormones. J Hypertens Suppl. 1988;6(4): S649S651.
  • Svartberg J., vo Muhlen D., Schirmer H., Barrett-Connor E., Sundfjord J., Jorde R.. Association of endogenous testosterone with blood pressure and left ventricular mass in men. The Tromso Study. Eur J Endocrinol. 2004;150(1): 6571.
  • Tsai EC, Matsumoto AM, Fujimoto WY, Boyko EJ. Association of bioavailable, free, and total testosterone with insulin resistance: influence of sex hormone-binding globulin and body fat. Diabetes Care. 2004;27(4): 861868.
  • Twigg J., Fulton N., Gomez E., Irvine DS, Aitken RJ. Analysis of the impact of intracellular reactive oxygen species generation on the structural and functional integrity of human spermatozoa: lipid peroxidation, DNA fragmentation and effectiveness of antioxidants. Hum Reprod. 1998;13(6): 14291436.
  • Vermeulen A., Kaufman JM, Giagulli VA. Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males. J Clin Endocrinol Metab. 1996;81(5): 18211826.
  • Organization World Health. WHO Laboratory Manual for the Examination of Human Semen and Sperm-Cervical Mucus Interaction. 4th ed. Cambridge, United Kingdom: Cambridge University Press; 1999.
  • Zumoff B., Strain GW, Miller LK, Rosner W., Senie R., Seres DS, Rosenfeld RS. Plasma free and non-sex-hormone-binding-globulin-bound testosterone are decreased in obese men in proportion to their degree of obesity. J Clin Endocrinol Metab. 1990;71(4): 929931.